Mizuho Maintains Outperform on Autolus Therapeutics, Lowers Price Target to $10
AUTOLUS THERAPEUTICS LTD
AUTOLUS THERAPEUTICS LTD AUTL | 0.00 |
Mizuho analyst Salim Syed maintains Autolus Therapeutics (NASDAQ:
AUTL) with a Outperform and lowers the price target from $12 to $10.
